C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1997
03/12/1997	CN1145077A Immuno-stimulatory monoclonal antibodies
03/12/1997	CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides
03/12/1997	CN1145020A Ancient organisms
03/12/1997	CN1144845A Fusion albumen of new human granulocyte macrophage colony stimulating factor
03/11/1997	US5610291 Glass fiber membranes modified by treatment with SiCl4, AlCl3 or BCl3 and washing with NaOH to set as a DNA Adsorbant
03/11/1997	US5610290 DNA purification by solid phase extraction using glass fiber membrane previously treated with trifluoroacetic acid, and then with fluoride ion, hydroxide ion, or Bcl3
03/11/1997	US5610288 Antisense polynucleotide inhibition of epidermal human growth factor receptor expression
03/11/1997	US5610287 Method for immobilizing nucleic acid molecules
03/11/1997	US5610286 DNA's encoding natural killer cell enhancing factor
03/11/1997	US5610282 cDNA encoding a rat D1 dopamine receptor linked to adenylyl cyclase activation and expression of the receptor protein in plasmid-transfected cell lines
03/11/1997	US5610280 Antitumor
03/11/1997	US5610279 Human TNF receptor
03/11/1997	US5610276 Determination whether a cell is cancerous
03/11/1997	US5610137 Transgenic, cross-linked hemoglobin
03/11/1997	US5610067 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products
03/11/1997	US5610063 Genetic engineering
03/11/1997	US5610057 Monoclonal antibody specific for IgA receptor
03/11/1997	US5610054 Enzymatic RNA molecule targeted against Hepatitis C virus
03/11/1997	US5610053 DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
03/11/1997	US5610052 Enzymatic RNA with activity to ras
03/11/1997	US5610050 Methods of preventing viral replication
03/11/1997	US5610049 Human rotavirus HCR3A and method of growing said rotavirus
03/11/1997	US5610048 Xylanase, DNA sequences, coding for the xylanases and methods of use thereof
03/11/1997	US5610046 Cloning and expression of xylanase B
03/11/1997	US5610044 Microorganisms with mannopine catabolizing ability
03/11/1997	US5610042 Bombardment of plant embryo with microprojectile dna coated particles
03/11/1997	US5610041 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants
03/11/1997	US5610036 Mutant AOX2 promoter, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism
03/11/1997	US5610034 Immunoglobulin production by trichoderma
03/11/1997	US5610031 B1k chain of laminin and methods of use
03/11/1997	US5610028 Genetically modified vibrio
03/11/1997	US5610019 Methods of detecting phospholipid transfer activity and kits therefor
03/11/1997	US5610018 Mitogenic signal transduction pathway
03/11/1997	US5610015 System to detect protein-RNA interactions
03/11/1997	US5610013 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
03/11/1997	US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods
03/11/1997	US5610009 Mammalian expression systems for hepatitis C virus envelope genes
03/11/1997	US5609826 Methods and apparatus for the generation of chemical libraries
03/11/1997	CA1338981C Biologically active proteins and a method for their production
03/06/1997	WO1997008553A1 Targeting of proteins to the cell wall of gram-positive bacteria
03/06/1997	WO1997008550A1 Retinoid x receptors and components of the basal transcription machinery
03/06/1997	WO1997008547A1 Method and apparatus for isolating nucleic acid
03/06/1997	WO1997008531A2 Detection of hepatitis gb virus genotypes
03/06/1997	WO1997008344A2 Method for identification of mutations using ligation of multiple oligonucleotide probes
03/06/1997	WO1997008342A1 Cytochrome p450 reporter gene
03/06/1997	WO1997008340A1 Amplification and detection of mycobacterium avium complex species
03/06/1997	WO1997008338A1 Atopy: diagnosis and therapy
03/06/1997	WO1997008335A1 Monoclonal antibody recognizing serum amyloid a
03/06/1997	WO1997008333A1 Process for producing l-amino acids
03/06/1997	WO1997008331A1 Stimulation of homologous recombination in eukaryotic organisms or cells by recombination promoting enzymes
03/06/1997	WO1997008330A1 Expression systems
03/06/1997	WO1997008329A1 Plastid inner envelope membrane targeting polypeptides; manufacture and use thereof
03/06/1997	WO1997008328A1 Selective elimination of t cells that recognize specific preselected targets
03/06/1997	WO1997008327A1 Herbicide-resistant acetolactate synthase gene
03/06/1997	WO1997008326A1 Method for cloning and expression of phosphorylation-dependent protein kinase
03/06/1997	WO1997008325A2 Purified coprinus laccases and nucleic acids encoding same
03/06/1997	WO1997008324A1 Methods for enhancing the production of interferon in cell culture
03/06/1997	WO1997008323A1 Staurosporin biosynthesis gene clusters
03/06/1997	WO1997008322A1 Mpt83 gene from mycobacterium tuberculosis
03/06/1997	WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/06/1997	WO1997008320A1 Protein/(poly)peptide libraries
03/06/1997	WO1997008319A1 Genetic alterations related to familial alzheimer's disease
03/06/1997	WO1997008318A2 Compounds and methods for treatment and diagnosis of prostate cancer
03/06/1997	WO1997008317A2 Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof
03/06/1997	WO1997008316A1 Mouse integrin subunits
03/06/1997	WO1997008315A1 Cloning methods for high strength spider silk proteins
03/06/1997	WO1997008314A2 Telomere repeat binding factor and diagnostic and therapeutic use thereof
03/06/1997	WO1997008313A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their production
03/06/1997	WO1997008312A1 Human jtv1 gene overlaps pms2 gene
03/06/1997	WO1997008311A1 Novel procollagens
03/06/1997	WO1997008310A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
03/06/1997	WO1997008309A2 Ribozyme therapy for hepatitis b infections
03/06/1997	WO1997008307A1 Heterologous protein production system using avian cells
03/06/1997	WO1997008306A1 Filtration processes, kits and devices for isolating plasmids
03/06/1997	WO1997008304A2 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease
03/06/1997	WO1997008303A1 Transgenic animals expressing diabetogenic t-cell receptor transgenes
03/06/1997	WO1997008301A1 Novel factors which modify gene transcription and methods of use therefor
03/06/1997	WO1997008299A1 Overproduction of neuronal nitric oxide synthase
03/06/1997	WO1997008298A1 Chromatographic purification of adenovirus and aav
03/06/1997	WO1997008297A1 Recombinant helicoverpa baculoviruses expressing heterologous dna
03/06/1997	WO1997008293A1 Release of intracellular material
03/06/1997	WO1997008292A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression
03/06/1997	WO1997008202A1 Antisecretory factor peptides regulating pathological permeability changes
03/06/1997	WO1997008201A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
03/06/1997	WO1997008199A2 Antimicrobial cationic peptides and methods of screening for the same
03/06/1997	WO1997008197A1 Dna sequence coding for a polypeptide which enhances virus infection of host insects
03/06/1997	WO1997008196A1 Neurturin and related growth factors
03/06/1997	WO1997008195A1 Ubiquitin conjugating enzymes having transcriptional repressor activity
03/06/1997	WO1997008186A1 Novel system for isolating and identifying eukaryotic cells transfected with genes and vectors
03/06/1997	WO1997008185A1 Use of a 5' positional primer to produce double-stranded dna from a dna template
03/06/1997	WO1997008184A1 Methods and compositions including dna damaging agents and tyrosine kinase inhibitors or activators
03/06/1997	WO1997008183A1 Nucleic acid capture moieties
03/06/1997	WO1997007828A1 Therapy for cellular accumulation in chronic inflammatory diseases
03/06/1997	WO1997007827A1 Gab1, A Grb2 BINDING PROTEIN, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
03/06/1997	WO1997007826A1 In vivo electroporation of cells
03/06/1997	WO1997007825A1 Circular rna and uses thereof
03/06/1997	WO1997007817A1 Multi-subtype fiv vaccines
03/06/1997	WO1997007815A2 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
03/06/1997	WO1997007808A1 Chimeric antiviral agents which incorporate rev binding nucleic acids
03/06/1997	WO1997007784A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES

1 ... 3643 3644 3645 3646 3647 3648 3649 3650 3651 3652 3653 3654 3655 3656 3657 3658 3659 3660 3661 3662 3663 ... 4023